Leptin, Ghrelin, and Adiponectin Evaluation in Transsexual Subjects During Hormonal Treatments
- 10 September 2008
- journal article
- research article
- Published by Wiley in Journal of Andrology
- Vol. 29 (5), 580-585
- https://doi.org/10.2164/jandrol.108.004952
Abstract
Gender differences in leptin, ghrelin, and adiponectin levels have been described in a normal population. This is important for understanding differences between males and females in the regulation of food intake, weight gain, body fat distribution, and cardiovascular risk. It is unclear how endogenous and exogenous sex hormones may regulate circulating levels of these factors. Transsexuals during hormonal treatment may represent an ideal model to ascertain the role of exogenous sex hormones on these parameters. In this study, our objective was to evaluate adiponectin, ghrelin, and leptin levels in transsexual subjects during hormone therapy and to compare the results of males and females. Subjects were 26 nondiabetic transsexuals, which included 15 male-to-female (M-to-F, group 3) and 11 female-to-male (F-to-M, group 4) individuals, and 29 age- and BMI-matched controls, which included 15 males (group 1) and 14 females (group 2). Results showed that leptin levels were significantly lower in group 1 compared with group 2 (P = .04) and group 3 (P = .01); no differences were recorded between the other groups. Adiponectin levels were significantly higher in group 3 compared with group 4 (P = .03). No differences were found between the 4 groups for ghrelin levels. In conclusion, our data confirm the sexual dimorphism in serum leptin levels in normal subjects and demonstrate an increase in M-to-F transsexuals. While ghrelin does not show any sexual differences and seems not to be influenced by exogenous sex hormone administration, the lower adiponectin levels in F-to-M transsexuals during treatment confirm that androgens may decrease plasma adiponectin levels. This latter observation suggests that F-to-M transsexual patients could have a higher cardiovascular risk.Keywords
This publication has 30 references indexed in Scilit:
- Adiponectin circulating levels: A new emerging biomarker of cardiovascular riskPharmacological Research, 2007
- Sex–specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo StudyClinical Endocrinology, 2006
- Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormonesInternational Journal of Obesity, 2006
- Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelinAmerican Journal of Obstetrics and Gynecology, 2006
- Leptin as a marker of sexual dimorphism in newborn infantsJornal de Pediatria, 2004
- Ghrelin secretion is modulated in a nutrient‐ and gender‐specific mannerClinical Endocrinology, 2004
- Plasma Adiponectin Concentration in Relation to Severity of Coronary Atherosclerosis and Cardiovascular Risk Factors in Middle-Aged MenEndocrine, 2004
- Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distributionInternational Journal of Obesity, 2001
- Reversal of the Sex Difference in Serum Leptin Levels upon Cross-Sex Hormone Administration in TranssexualsJournal of Clinical Endocrinology & Metabolism, 1997
- Sexual Dimorphism in Plasma Leptin ConcentrationJournal of Clinical Endocrinology & Metabolism, 1997